Source: ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley. ICS-formoterol reliever versus ICS and short-acting ß₂-agonist reliever in asthma: a systematic review and meta-analysis. ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020

Member's Comments

No comment yet.

Related content which might interest you:

• ERS practice guidelines for the diagnosis of asthma in children aged 5 to 16 years
• Does inhaled corticosteroid use affect the risk of ?COVID-19-related death?
• The impact of anti-IgE treatment on the airway microbiome in asthma.